Community-associated Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis among HIV Patients: A cohort study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Furuno, Jon P ^a,b   Johnson, Jennifer K ^b   Schweizer, Marin L ^c   Uche, Anayochukwu ^d   Stine, Oscar C ^b   Shurland, Simone M ^b,e   Forrest, Graeme N ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Oro Valley   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ARGININE; CD4 ANTIGEN; CLINDAMYCIN; COTRIMOXAZOLE; METICILLIN; PANTON VALENTINE LEUKOCIDIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS PROTEIN A; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; POPULATION RESEARCH; UNITED STATES; BACTEREMIA; COMMUNICABLE DISEASE; GENETICS; INTERSPERSED REPEAT; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PREVALENCE; RISK FACTOR; STAPHYLOCOCCUS INFECTION; SURVIVAL;

ADULT; BACTEREMIA; BACTERIAL TOXINS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; ENDOCARDITIS, BACTERIAL; EXOTOXINS; FEMALE; HIV INFECTIONS; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; LEUKOCIDINS; MALE; MARYLAND; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; SURVIVAL ANALYSIS; VIRULENCE FACTORS;

EID: 80054972842     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-298     Document Type: Article

References (43)

1. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476, 12491202.
2. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006, 42(Suppl 2):S82-S89.
3. Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006, 43:426-432. 10.1097/01.qai.0000243120.67529.78, 17099314.
4. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008, 46:787-794. 10.1086/528716, 18266611.
5. Cicalini S, Forcina G, De Rosa FG. Infective endocarditis in patients with human immunodeficiency virus infection. J Infect 2001, 42:267-271. 10.1053/jinf.2001.0812, 11545570.
6. De Rosa FG, Cicalini S, Canta F, Audagnotto S, Cecchi E, Di PG. Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients. Infection 2007, 35:154-160. 10.1007/s15010-007-5125-0, 17565456.
7. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879.
8. Pan ES, Diep BA, Carleton HA, Charlebois ED, Sensabaugh GF, Haller BL, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003, 37:1384-1388. 10.1086/379019, 14583874.
9. Burkey MD, Wilson LE, Moore RD, Lucas GM, Francis J, Gebo KA. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med 2008, 9:858-862. 2581476, 18754806.
10. Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia. J Infect 2010, 61:372-381. 10.1016/j.jinf.2010.09.021, 2975870, 20868707.
11. AIDS Administration Maryland Department of Health and Mental Hygiene The Maryland 2009 HIV/AIDS annual report. 2009, 2008. AIDS Administration Maryland Department of Health and Mental Hygiene.
12. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771. 10.1001/jama.298.15.1763, 17940231.
13. Weber SG, Miller RR, Perencevich EN, Tolentino J, Meltzer D, Pitrak D, et al. Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study. J Antimicrob Chemother 2009, 64:1291-1298. 10.1093/jac/dkp349, 2775664, 19808237.
14. McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc 2006, 13:378-384. 10.1197/jamia.M2049, 1513678, 16622162.
15. Wright MO, Perencevich EN, Novak C, Hebden JN, Standiford HC, Harris AD. Preliminary assessment of an automated surveillance system for infection control. Infect Control Hosp Epidemiol 2004, 25:325-332. 10.1086/502400, 15108731.
16. Furuno JP, McGregor JC, Harris AD, Johnson JA, Johnson JK, Langenberg P, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006, 166:580-585. 10.1001/archinte.166.5.580, 16534047.
17. Furuno JP, Harris AD, Wright MO, Hartley DM, McGregor JC, Gaff HD, et al. Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007, 28:666-670. 10.1086/518348, 17520538.
18. Schweizer ML, Furuno JP, Harris AD, McGregor JC, Thom KA, Johnson JK, et al. Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy. Infect Control Hosp Epidemiol 2008, 29:972-974. 10.1086/590665, 2853911, 18793097.
19. KDOQI Clinical Practice Guidelines For Chronic Kidney Disease: Evaluation, Classification and Stratification. National Kidney Foundation 2002,
20. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638. 10.1086/313753, 10770721.
21. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Approved Standard Document M100-S17. 2007, Wayne, Pa, Clinical and Laboratory Standards Institute.
22. Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JG, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 2005, 11:1539-1544.
23. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003, 41:5442-5448. 10.1128/JCM.41.12.5442-5448.2003, 309029, 14662923.
24. Shopsin B, Gomez M, Waddington M, Riehman M, Kreiswirth BN. Use of coagulase gene (coa) repeat region nucleotide sequences for typing of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 2000, 38:3453-3456. 87405, 10970402.
25. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739. 10.1016/S0140-6736(06)68231-7, 16517273.
26. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132. 10.1086/313461, 10524952.
27. Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis 2007, 13:1195-1200. 2828080, 17953091.
28. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003, 41:5113-5120. 10.1128/JCM.41.11.5113-5120.2003, 262524, 14605147.
29. Lalani T, Federspiel JJ, Boucher HW, Rude TH, Bae IG, Rybak MJ, et al. Associations between the Genotype of Staphylococcus aureus Bloodstream Isolates and the Clinical Characteristics and Outcomes of Bacteremic Patients. J Clin Microbiol 2008,
30. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008, 46:799-806. 10.1086/527389, 18266610.
31. Beeston CJ, Gupta R, Chadwick PR, Young RJ. Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital. Eur J Clin Microbiol Infect Dis 2009, 28:585-590. 10.1007/s10096-008-0675-3, 19067002.
32. Chen SY, Wang JT, Chen TH, Lai MS, Chie WC, Chien KL, et al. Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia. Medicine (Baltimore) 2010, 89:285-294.
33. Robinson JO, Pearson JC, Christiansen KJ, Coombs GW, Murray RJ. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2009, 28:353-361. 10.1007/s10096-008-0632-1, 18850122.
34. Wang JT, Wang JL, Fang CT, Chie WC, Lai MS, Lauderdale TL, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. J Infect 2010, 61:449-457. 10.1016/j.jinf.2010.09.029, 20875455.
35. Kreisel KM, Stine OC, Johnson JK, Perencevich EN, Shardell MD, Lesse AJ, et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?. Diagn Microbiol Infect Dis 2011, 70:285-290. 10.1016/j.diagmicrobio.2011.03.010, 21558047.
36. Kreisel KM, Johnson JK, Stine OC, Shardell MD, Perencevich EN, Lesse AJ, et al. Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia. Emerg Infect Dis 2010, 16:1419-1427.
37. Chua T, Moore CL, Perri MB, Donabedian SM, Masch W, Vager D, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J Clin Microbiol 2008, 46:2345-2352. 10.1128/JCM.00154-08, 2446903, 18508934.
38. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998, 280:544-546. 10.1001/jama.280.6.544, 9707145.
39. Mehta SH, Kirk GD, Astemborski J, Galai N, Celentano DD. Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008. Clin Infect Dis 2010, 50:1664-1671. 10.1086/652867, 2874101, 20450418.
40. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003, 89:577-581. 10.1136/heart.89.5.577, 1767660, 12695478.
41. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007, 45:329-337. 10.1086/519283, 17599310.
42. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am Heart J 2004, 147:536-539. 10.1016/j.ahj.2003.09.018, 14999206.
43. Ellington MJ, Hope R, Ganner M, Ganner M, East C, Brick G, et al. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?. J Antimicrob Chemother 2007, 60:402-405. 10.1093/jac/dkm206, 17562682.